The present review summarizes the current state of knowledge about the genetics of pain-related phenomena and illustrates the scope and power of genetic approaches to the study of pain. We 
It is widely appreciated among clinicians and researchers that sensitivity to pain and responses to analgesics are highly variable. Beecher (1) reported that some soldiers wounded in battle did not require morphine, and Lasagna and Beecher (2) found that standard 10-mg doses of morphine inadequately relieved postoperative pain in up to 35% of patients. Conversely, some people exhibit marked analgesia from placebo alone (3) . The analgesic efficacy of morphine and other opiates is known to depend on many factors related to the drug, the patient, and the nature of the pain itself (4, 5) . With respect to patient-related variability, some combination of genetic factors-e.g., sensitivity to the noxious stimulus, inborn personality variables, and gender-and environmental influencese.g., learned personality variables, gender and attractiveness of the experimenter, subject's mood during testing, and time of day-must be responsible. A similar constellation of genetic and environmental factors no doubt underlies the considerable variation noted in clinically significant pain syndromes. Studies show significant correlations between pain report and behavior of family members (6, 7) , but interpretations of shared socialization have tended to predominate over genetic explanations.
In fact, the study of genetic differences in pain-related traits has been largely neglected. One reason may be that pain research has been blessed by the discovery of endogenous opioid peptides and the development of an abundance of increasingly specific opiate receptor ligands. Genetic approaches to the study of pain, therefore, have been largely overlooked in favor of pharmacological interventions. In general, these experiments have been quite successful, elucidating the physiology and neurochemistry of pain transmission and modulation to an impressive degree of detail (8, 9) . There exist, however, some aspects of pain neurobiology that cannot be adequately addressed without the use of genetic techniques. Standard biological techniques attempt to obtain information about all members of the species under study; in effect, to learn about the "universal rat." The very purpose of the genetic approach, on the other hand, is to explain individual differences. As (10) . A number of pain-related traits are known to have comparatively high heritability and, thus, are open to genetic investigation. Once a trait has been shown to be at least partially determined by genetic factors, biometric analyses can be performed to determine the mode of inheritance-i.e., dominant or recessive-effects of natural selection, and how many genes mediate the trait (11) . Another use of genetic techniques is to establish correlation or dissociation between traits; the genetic covariation of two traits represents evidence of a functional relationship between them (12, 13) . Such studies have proven to be especially useful for the generation of hypotheses regarding underlying physiological mechanisms. Finally, the use of classical genetic techniques can render a trait amenable to powerful molecular genetic analyses. It is now possible to map trait-relevant loci onto the genome of many organisms (especially mice and humans), even for traits determined by multiple genes and even in the absence of plausible candidate genes (14, 15) . Once mapping is accomplished, the genes controlling the trait of interest can be identified and cloned, and the specific influence of each gene on the trait can then be examined in isolation. Thus (29) .
Recombinant inbred (RI) strains. The existence of large and reliable inbred strain differences has encouraged the production of more complex but more useful genetic models, such as RI strain sets (30, 31 (33) . Surveys of such mutants have identified some that display differential opiate analgesic sensitivity. These include the mutations Sepia and Gunmetal (34) , Jimpy (B6CBA-AW-J/A-Ta jp) (35) , and Beige-J (C57BL/6J-bgJ) (36) . Sepia and Gunmetal mice, bearing mutations on chromosomes 1 and 14, respectively, display more potent morphine analgesia than do B6 mice (34) . Beige-J mice display markedly less opiate analgesia than do B6 mice (36, 37) , a deficit that seems to be related to an abnormal circulating splenic factor (38 Nonetheless, overwhelming evidence exists that genes specifically underlying opioid (and nonopioid) mechanisms of endogenous pain inhibition have also been altered by selection. SIA in HA but not LA mice is attenuated by naloxone (89, 90, 96, 101), which has no effect on swim hypothermia (102) . Adrenalectomy increases SIA magnitude in HA but not LA mice, and this effect is reversed by dexamethasone, supporting the hypothesis that the pituitary/adrenal axis has been altered in these animals (105) . The administration of D-amino acids (enkephalinase inhibitors) facilitates SIA in HA but not in LA mice (106) . In addition to SIA differences, HA (110) . A randomly bred control line was maintained concurrently. In each successive generation, levorphanol doses were chosen to produce equipotent analgesia in each line to facilitate the identification of extreme responders. Significant line differences were evident by the third selected generation, and the realized heritability was estimated as h2 = 0.32.
The HAR/LAR lines have been used largely to identify compounds sharing similarity in drug action with levorphanol; that is, to identify correlated pharmacological responses. In one study, dose-response relationships in HAR and LAR mice were evaluated for a number of analgesic compounds, and the slopes of the dose-response curves were compared. HAR to LAR slope ratios were observed in the following rank order: morphine > levorphanol > pentazocine > ethylketocyclazocine > U50,488H > clonidine (111) . In a similar study, this rank ordering was observed: DAMGO > DADLE > [D-Ser2,Leu5]enkephalinyl-Thr (DSLET) > DPDPE (83, 112).
These data sets thus reveal that selection has predominantly affected ,1-over K-opioid (111), 8-opioid (83, 112) , and nonopioid (111) receptor mechanisms.
No differences in opiate pharmacokinetics were seen between HAR and LAR mice, and whole-brain-homogenate binding revealed no meaningful line differences (111) . However, quantitative autoradiographic studies using [3H]DAMGO revealed large (nearly 2-fold) differences in the dorsal raphe nucleus (DRN) (113) , a brain area known to be involved in nociceptive processing (8) . There are anatomical connections between the DRN and the medial thalamus (the brain area displaying highly differential ,t-receptor density in HA vs. LA mice; see above), and DRN stimulation can inhibit nociceptive units in the medial thalamus (114, 115 (118) . Even when the nerve injury is similar, deafferentation pain in humans and autotomy in rodents show great individual variability in their expression. Starting with Sabra strain (Wistar) rats, these investigators selected for high and low autotomy scores following the unilateral sectioning of the sciatic and saphenous nerves (117) . generations of successful selection, Mendelian test crosses were made as described above, and the data strongly suggested that propensity to autotomize is inherited through a single major recessive gene. Unoperated rats of these two selection lines have been found to differ in their responsivity to both mechanical and thermal nociceptive stimuli (119) (31, 42) , but theoretical advances (125, 126) and the wide availability of easily genotyped, polymorphic DNA markers of known location (15) (130) . The resultant knockout mice express a truncated POMC prohormone, and although other POMC products-e.g., corticotropin and a-melanocyte-stimulating hormone) are produced normally in these animals, /3-endorphin cannot be detected (131) . Although these mice display no overt developmental or behavioral alterations and exhibit unchanged morphine analgesic sensitivity, they appear to be devoid of opioid-mediated swim SIA. Intriguingly, they also display upregulated nonopioid swim SIA and paradoxical naloxone-induced analgesia, both of which may reflect compensatory responses to the lack of 3-endorphin (131 The existence of a number of genetic models displaying large divergence in analgesic sensitivity clearly illustrates that these traits are heritable and amenable to study. The characterization of these models is encouraged by the repeated demonstration that only relatively simple genetic alterations-i.e., the effects of a few genes-are sufficient to produce the extreme responses of HA/LA, HAR/LAR, and CXBK mice (83, 108, 116 
